MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation suspension for ...
Dealbreaker on MSN
Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario
Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial ...
Three of Anthropic’s Claude Desktop extensions were vulnerable to command injection – flaws that have now been fixed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback